The COVID booster currently available is based on the JN.1 subvariant. Nimbus is a direct descendant of JN.1 – as is another ...

John Stewart, Director of Specialised Commissioning at NHS England said: “For babies born very prematurely, the risk of ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of newborns with severe lung infections. By passing virus-fighting antibodies to ...

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, ...

Rehospitalization for RSV within the same season was rare, suggesting limited need for routine additional monoclonal antibody ...

New UK data shows RSV vaccines in pregnant women cut infant hospitalizations by 72%, while premature babies are now protected ...

Premature babies in the UK will soon be protected against respiratory syncytial virus (RSV) through a new immunisation programme using nirsevimab. The initiative aims to reduce hospitalisation and ...

NHS England » NHS to roll out long-lasting ‘suit of armour’ jab to protect thousands of premature babies from RSV ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...